April, 2024
April 2024
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
2930  
Cancer and Crisis Talks with Jemma Arakelyan #3 – Dr. Nazik Hammad
Mar 26, 2024, 14:54

Cancer and Crisis Talks with Jemma Arakelyan #3 – Dr. Nazik Hammad

We are thrilled to unveil the next captivating episode of our enlightening series, “Cancer and Crisis Talks”, hosted by the remarkable Dr. Jemma Arakelyan. In our ongoing mission to shed light on the unique challenges faced by cancer care providers and patients during times of crisis, we are honored to present our distinguished guest for this episode: Dr. Nazik Hammad.

About Dr. Nazik Hammad:

Nazik Hammad is a Sudanese Canadian Professor of medical oncology, at Saint Michael Hospital, Department of Medicine, University of Toronto.  Her academic work and research interests include medical education and workforce development in low and middle-income countries (LMIC) particularly in sub-Saharan Africa. Other research and academic interests include value-based cancer care, global and local inequities and disparities in cancer, global health and global oncology, women as health care professionals and cancer in conflict zones. Together with colleagues in Africa she led the first Choosing Wisely Africa initiative. She is a co-author in the Lancet Oncology commission for Cancer in Sub-Saharan Africa and is a commissioner in the Lancet Commission on Women, Power and Cancer.

About Dr. Jemma Arakelyan:

The host, Dr. Jemma Arakelyan, is a medical oncologist and a Ph.D. candidate at the City University of Hong Kong. Having graduated from both Yerevan State Medical University and Harvard Medical School, she is currently immersed in pursuing a Ph.D. in the dynamic field of anticancer drug discovery at the Drug Discovery Lab, City University of Hong Kong. Here, her research pursuits are pioneering innovative strategies to combat cancer and unearth novel therapeutic avenues for patients. Beyond academia, Dr. Arakelyan is deeply involved as an ESCO Fellow and an influential adviser at the Immune Oncology Research Institute. Since June 2023, she has been appointed the CEO of the Institute of Cancer and Crisis, overseeing initiatives to tackle cancer in the face of challenging circumstances.